Novo Nordisk's stock down 4% as the Feds get ready for a second round of drug price negotiations
Medicare released its next target list of 15 drugs to negotiate prices of, including Novo Nordisk's blockbuster GLP-1 drugs.
Bristol Myers Squibb says Alzheimer's is the biggest market for new schizophrenia drug
Bristol Myers Squibb plans to release initial late-stage trial data on Cobenfy in Alzheimer's-related psychosis during the ...
The FDA Proposes a De Facto Cigarette Ban, Which Would Expand the Disastrous War on Drugs
On its way out the door, the Biden administration has proposed a rule that would effectively ban cigarettes by requiring a ...
Crain's New York1d
Midtown-based drug company raises $23M in attempt to defy aging
A Midtown-based therapeutics company hopes to tap the growing market of anti-aging drugs with a suite of pharmaceutical ...
NYC to Open 2,200-Bed Migrant Shelter for Single Men Near Open-Air Drug Market
Retrofitting the building for the new shelter will reportedly cost the Democrat-run sanctuary city between $250,000 and ...
El País in English38m
What are the limits in the fight against obesity? Ozempic owner disappoints the market
Novo Nordisk, the largest European company by market capitalization, has achieved worse than expected results for its new slimming drug CagriSema ...
Wockhardt’s ‘miracle drug’ Zaynich: Can it revive the antibiotics market and the company’s fortunes?
Wockhardt’s experimental drug, Zaynich, has shown impressive results, achieving a 100% cure rate in clinical trials for ...
NOLA.com3d
Can weight loss drugs curb alcohol addictions? New research looks at the possibility.
Can weight loss drugs curb alcohol addictions? This Louisiana doctor is keeping an eye on new findings and emerging research.
Novo Suffers Wegovy Trial Setback as US Plans to Cut Price
Novo Nordisk A/S’s blockbuster drug Wegovy was targeted for price cuts by the US government and suffered a setback in a new ...